BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 32638069)

  • 1. Neuronal Cav3 channelopathies: recent progress and perspectives.
    Lory P; Nicole S; Monteil A
    Pflugers Arch; 2020 Jul; 472(7):831-844. PubMed ID: 32638069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ca
    El Ghaleb Y; Flucher BE
    Handb Exp Pharmacol; 2023; 279():263-288. PubMed ID: 36592228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic T-type calcium channelopathies.
    Weiss N; Zamponi GW
    J Med Genet; 2020 Jan; 57(1):1-10. PubMed ID: 31217264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysing an allelic series of rare missense variants of CACNA1I in a Swedish schizophrenia cohort.
    Baez-Nieto D; Allen A; Akers-Campbell S; Yang L; Budnik N; Pupo A; Shin YC; Genovese G; Liao M; Pérez-Palma E; Heyne H; Lal D; Lipscombe D; Pan JQ
    Brain; 2022 Jun; 145(5):1839-1853. PubMed ID: 34919654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CACNA1I gain-of-function mutations differentially affect channel gating and cause neurodevelopmental disorders.
    El Ghaleb Y; Schneeberger PE; Fernández-Quintero ML; Geisler SM; Pelizzari S; Polstra AM; van Hagen JM; Denecke J; Campiglio M; Liedl KR; Stevens CA; Person RE; Rentas S; Marsh ED; Conlin LK; Tuluc P; Kutsche K; Flucher BE
    Brain; 2021 Aug; 144(7):2092-2106. PubMed ID: 33704440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic alteration of the metal/redox modulation of Cav3.2 T-type calcium channel reveals its role in neuronal excitability.
    Voisin T; Bourinet E; Lory P
    J Physiol; 2016 Jul; 594(13):3561-74. PubMed ID: 26931411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Recurrent Mutation in CACNA1G Alters Cav3.1 T-Type Calcium-Channel Conduction and Causes Autosomal-Dominant Cerebellar Ataxia.
    Coutelier M; Blesneac I; Monteil A; Monin ML; Ando K; Mundwiller E; Brusco A; Le Ber I; Anheim M; Castrioto A; Duyckaerts C; Brice A; Durr A; Lory P; Stevanin G
    Am J Hum Genet; 2015 Nov; 97(5):726-37. PubMed ID: 26456284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Channelopathies of voltage-gated L-type Cav1.3/α
    Torrente AG; Mesirca P; Bidaud I; Mangoni ME
    Pflugers Arch; 2020 Jul; 472(7):817-830. PubMed ID: 32601767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular biology of T-type calcium channels.
    Perez-Reyes E; Lory P
    CNS Neurol Disord Drug Targets; 2006 Dec; 5(6):605-9. PubMed ID: 17168745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of T-type calcium channels: signalling pathways and functional implications.
    Huc S; Monteil A; Bidaud I; Barbara G; Chemin J; Lory P
    Biochim Biophys Acta; 2009 Jun; 1793(6):947-52. PubMed ID: 19071165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms by which a CACNA1H mutation in epilepsy patients increases seizure susceptibility.
    Eckle VS; Shcheglovitov A; Vitko I; Dey D; Yap CC; Winckler B; Perez-Reyes E
    J Physiol; 2014 Feb; 592(4):795-809. PubMed ID: 24277868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splice-variant-specific effects of primary aldosteronism point mutations on human Ca
    He M; Xu Z; Zhang Y; Hu C
    Cell Calcium; 2019 Dec; 84():102104. PubMed ID: 31706065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hallmarks of the channelopathies associated with L-type calcium channels: a focus on the Timothy mutations in Ca(v)1.2 channels.
    Bidaud I; Lory P
    Biochimie; 2011 Dec; 93(12):2080-6. PubMed ID: 21664226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of T-type calcium channels.
    Perez-Reyes E
    Cell Calcium; 2006 Aug; 40(2):89-96. PubMed ID: 16759699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo mutation screening in childhood-onset cerebellar atrophy identifies gain-of-function mutations in the CACNA1G calcium channel gene.
    Chemin J; Siquier-Pernet K; Nicouleau M; Barcia G; Ahmad A; Medina-Cano D; Hanein S; Altin N; Hubert L; Bole-Feysot C; Fourage C; Nitschké P; Thevenon J; Rio M; Blanc P; Vidal C; Bahi-Buisson N; Desguerre I; Munnich A; Lyonnet S; Boddaert N; Fassi E; Shinawi M; Zimmerman H; Amiel J; Faivre L; Colleaux L; Lory P; Cantagrel V
    Brain; 2018 Jul; 141(7):1998-2013. PubMed ID: 29878067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiological characterization of a Ca
    Stringer RN; Cmarko L; Zamponi GW; De Waard M; Weiss N
    Mol Brain; 2023 Sep; 16(1):68. PubMed ID: 37735453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanded alternative splice isoform profiling of the mouse Cav3.1/alpha1G T-type calcium channel.
    Ernst WL; Noebels JL
    BMC Mol Biol; 2009 May; 10():53. PubMed ID: 19480703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Versatile Clustered Regularly Interspaced Palindromic Repeats Toolbox to Study Neurological Ca
    Tsortouktzidis D; Tröscher AR; Schulz H; Opitz T; Schoch S; Becker AJ; van Loo KMJ
    Front Mol Neurosci; 2021; 14():667143. PubMed ID: 35069110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zonisamide can ameliorate the voltage-dependence alteration of the T-type calcium channel Ca
    Hara N; Morino H; Matsuda Y; Satoh K; Hashimoto K; Maruyama H; Kawakami H
    Mol Brain; 2020 Nov; 13(1):163. PubMed ID: 33243296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CACNA1H missense mutations associated with amyotrophic lateral sclerosis alter Cav3.2 T-type calcium channel activity and reticular thalamic neuron firing.
    Rzhepetskyy Y; Lazniewska J; Blesneac I; Pamphlett R; Weiss N
    Channels (Austin); 2016 Nov; 10(6):466-77. PubMed ID: 27331657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.